1
|
Zhu L, Pan Z, Li Z, Chang Y, Zhu Y, Yan F, Tu S, Yang W. Can the Wall Shear Stress Values of Left Internal Mammary Artery Grafts during the Perioperative Period Reflect the One-Year Patency? Thorac Cardiovasc Surg 2020; 68:723-729. [PMID: 32937666 DOI: 10.1055/s-0040-1714385] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
PURPOSE The left internal mammary artery (LIMA) is the preferred graft for coronary artery bypass grafting, but the reasoning for LIMA occlusion is unclear. We sought to examine whether the wall shear stress (WSS) values of LIMA grafts during the perioperative period reflected the 1-year patency by using combining computational fluid dynamics (CFD) and coronary computed tomography angiography (CCTA) images. METHODS CCTA was performed in 233 patients with LIMA graft perioperatively and 1 year later from October 2014 to May 2017. LIMA occlusion was detected in six patients at the 1-year follow-up CCTA. Two patients were excluded due to poor imaging quality. The remaining four patients were enrolled as occlusive (OCC) group, and eight patients with patent LIMA were recruited as patent (PAT) group. The WSS values of LIMA during perioperative period were calculated. LIMA graft was artificially divided into three even segments, proximal (pLIMA), middle (mLIMA) and distal (dLIMA) segments. The independent samples t-test and the Student-Newman-Keuls test were used. RESULTS The WSS values of dLIMA were significantly higher in the PAT group than in the OCC group (4.43 vs. 2.56, p < 0.05). The WSS values of dLIMA in the PAT group were significantly higher than pLIMA, which was absent in the OCC group. CONCLUSIONS A higher WSS value of the distal segment of LIMA and a higher WSS value of the distal segment compared with the proximal segment of LIMA in the PAT were observed; this tendency might be helpful in predicting the 1-year patency of LIMA.
Collapse
Affiliation(s)
- Lan Zhu
- Department of Radiology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Zilai Pan
- Department of Radiology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Zehang Li
- Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Yunxiao Chang
- Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Yunpeng Zhu
- Department of Cardiac Surgery, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Fuhua Yan
- Department of Radiology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| | - Shengxian Tu
- Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Wenjie Yang
- Department of Radiology, Ruijin Hospital affiliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, China
| |
Collapse
|
2
|
Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, Di Giammarco G, Fremes S, Glineur D, Grau J, He GW, Marinelli D, Ohmes LB, Patrono C, Puskas J, Tranbaugh R, Girardi LN, Taggart DP, Ruel M, Bakaeen FG. Mechanisms, Consequences, and Prevention of Coronary Graft Failure. Circulation 2017; 136:1749-1764. [DOI: 10.1161/circulationaha.117.027597] [Citation(s) in RCA: 138] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Mario Gaudino
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Charalambos Antoniades
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Umberto Benedetto
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Saswata Deb
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Antonino Di Franco
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Gabriele Di Giammarco
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Stephen Fremes
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - David Glineur
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Juan Grau
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Guo-Wei He
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Daniele Marinelli
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Lucas B. Ohmes
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Carlo Patrono
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - John Puskas
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Robert Tranbaugh
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Leonard N. Girardi
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - David P. Taggart
- From Department of Cardiothoracic Surgery, @Weill Cornell Medicine, New York (M.G., A.D.F., L.B.O., R.T., L.N.G.); Department of Medicine and Department of Cardiovascular Surgery, John Radcliffe Hospital, University of Oxford, UK (C.A., D.P.T.); Bristol Heart Institute, University of Bristol, School of Clinical Sciences, UK (U.B.); Schulich Heart Centre, Sunnybrook Health Science, University of Toronto, Canada (S.D., S.F.); University “G. D’Annunzio,” Chieti, Italy (G.D.G., D.M.); Division of
| | - Marc Ruel
- Division of Cardiac Surgery, School of Epidemiology, Public Health, and Preventive Medicine, University of Ottawa, Canada
| | - Faisal G. Bakaeen
- Department of Cardiovascular Surgery, Texas Heart Institute, Houston, and Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX
| |
Collapse
|
3
|
Gansera B. Postoperative Ergebnisse nach A.-thoracica-interna-Bypass. ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE 2016. [DOI: 10.1007/s00398-016-0098-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Fan T, Lu Y, Gao Y, Meng J, Tan W, Huo Y, Kassab GS. Hemodynamics of left internal mammary artery bypass graft: Effect of anastomotic geometry, coronary artery stenosis, and postoperative time. J Biomech 2016; 49:645-652. [DOI: 10.1016/j.jbiomech.2016.01.031] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2015] [Revised: 01/02/2016] [Accepted: 01/28/2016] [Indexed: 01/22/2023]
|
5
|
Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Circulation 2015; 133:131-8. [PMID: 26647082 DOI: 10.1161/circulationaha.115.015549] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2015] [Accepted: 10/23/2015] [Indexed: 11/16/2022]
Abstract
BACKGROUND The internal mammary artery (IMA) is the preferred conduit for bypassing the left anterior descending (LAD) artery in patients undergoing coronary artery bypass grafting. Systematic evaluation of the frequency and predictors of IMA failure and long-term outcomes is lacking. METHODS AND RESULTS The Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV trial participants who underwent IMA-LAD revascularization and had 12- to 18-month angiographic follow-up (n=1539) were included. Logistic regression with fast false selection rate methods was used to identify characteristics associated with IMA failure (≥75% stenosis). The relationship between IMA failure and long-term outcomes, including death, myocardial infarction, and repeat revascularization, was assessed with Cox regression. IMA failure occurred in 132 participants (8.6%). Predictors of IMA graft failure were LAD stenosis <75% (odds ratio, 1.76; 95% confidence interval, 1.19-2.59), additional bypass graft to diagonal branch (odds ratio, 1.92; 95% confidence interval, 1.33-2.76), and not having diabetes mellitus (odds ratio, 1.82; 95% confidence interval, 1.20-2.78). LAD stenosis and additional diagonal graft remained predictive of IMA failure in an alternative model that included angiographic failure or death before angiography as the outcome. IMA failure was associated with a significantly higher incidence of subsequent acute (<14 days of angiography) clinical events, mostly as a result of a higher rate of repeat revascularization. CONCLUSIONS IMA failure was common and associated with higher rates of repeat revascularization, and patients with intermediate LAD stenosis or with an additional bypass graft to the diagonal branch had increased risk for IMA failure. These findings raise concerns about competitive flow and the benefit of coronary artery bypass grafting in intermediate LAD stenosis without functional evidence of ischemia. CLINICAL TRIAL REGISTRATION URL: http:/www.clinicaltrials.gov. Unique identifier: NCT00042081.
Collapse
Affiliation(s)
- Ralf E Harskamp
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - John H Alexander
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - T Bruce Ferguson
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Rebecca Hager
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Michael J Mack
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Brian Englum
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Daniel Wojdyla
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Phillip J Schulte
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Nicholas T Kouchoukos
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Robbert J de Winter
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - C Michael Gibson
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Eric D Peterson
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Robert A Harrington
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Peter K Smith
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.)
| | - Renato D Lopes
- From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.E.H., J.H.A., B.E., D.W., P.J.S., E.D.P., P.K.S., R.D.L.); Department of Cardiology, Academic Medical Center - University of Amsterdam, Amsterdam, The Netherlands (R.E.H., R.J.d.W.); East Carolina University, Greenville, NC (T.B.F.); North Carolina State University, Raleigh (R.H.); Cardiopulmonary Research Science and Technology Institute, Dallas, TX (M.J.M.); Missouri Baptist Medical Center, St Louis (N.T.K.); PERFUSE Angiographic Laboratory, Boston, MA (C.M.G.); and Department of Medicine, Stanford University, Stanford, CA (R.A.H.).
| |
Collapse
|
6
|
Gaudino M, Massetti M, Farina P, Hanet C, Etienne PY, Mazza A, Glineur D. Chronic competitive flow from a patent arterial or venous graft to the circumflex system does not impair the long-term patency of internal thoracic artery to left anterior descending grafts in patients with isolated predivisional left main disease: Long-term angiographic results of 2 different revascularization strategies. J Thorac Cardiovasc Surg 2014; 148:1856-9. [DOI: 10.1016/j.jtcvs.2014.02.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2013] [Revised: 01/20/2014] [Accepted: 02/03/2014] [Indexed: 11/25/2022]
|
7
|
Ghista DN, Kabinejadian F. Coronary artery bypass grafting hemodynamics and anastomosis design: a biomedical engineering review. Biomed Eng Online 2013; 12:129. [PMID: 24330653 PMCID: PMC3867628 DOI: 10.1186/1475-925x-12-129] [Citation(s) in RCA: 68] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2013] [Accepted: 12/10/2013] [Indexed: 12/24/2022] Open
Abstract
In this paper, coronary arterial bypass grafting hemodynamics and anastomosis designs are reviewed. The paper specifically addresses the biomechanical factors for enhancement of the patency of coronary artery bypass grafts (CABGs). Stenosis of distal anastomosis, caused by thrombosis and intimal hyperplasia (IH), is the major cause of failure of CABGs. Strong correlations have been established between the hemodynamics and vessel wall biomechanical factors and the initiation and development of IH and thrombus formation. Accordingly, several investigations have been conducted and numerous anastomotic geometries and devices have been designed to better regulate the blood flow fields and distribution of hemodynamic parameters and biomechanical factors at the distal anastomosis, in order to enhance the patency of CABGs. Enhancement of longevity and patency rate of CABGs can eliminate the need for re-operation and can significantly lower morbidity, and thereby reduces medical costs for patients suffering from coronary stenosis. This invited review focuses on various endeavors made thus far to design a patency-enhancing optimized anastomotic configuration for the distal junction of CABGs.
Collapse
Affiliation(s)
| | - Foad Kabinejadian
- Department of Biomedical Engineering, National University of Singapore, 9 Engineering Drive 1, Block EA #03-12, Singapore 117576, Singapore.
| |
Collapse
|
8
|
Nordgaard H, Swillens A, Nordhaug D, Kirkeby-Garstad I, Van Loo D, Vitale N, Segers P, Haaverstad R, Lovstakken L. Impact of competitive flow on wall shear stress in coronary surgery: computational fluid dynamics of a LIMA-LAD model. Cardiovasc Res 2010; 88:512-9. [PMID: 20581004 DOI: 10.1093/cvr/cvq210] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
AIMS Competitive flow from native coronary vessels is considered a major factor in the failure of coronary bypass grafts. However, the pathophysiological effects are not fully understood. Low and oscillatory wall shear stress (WSS) is known to induce endothelial dysfunction and vascular disease, like atherosclerosis and intimal hyperplasia. The aim was to investigate the impact of competitive flow on WSS in mammary artery bypass grafts. METHODS AND RESULTS Using computational fluid dynamics, WSS was calculated in a left internal mammary artery (LIMA) graft to the left anterior descending artery in a three-dimensional in vivo porcine coronary artery bypass graft model. The following conditions were investigated: high competitive flow (non-significant coronary lesion), partial competitive flow (significant coronary lesion), and no competitive flow (totally occluded coronary vessel). Time-averaged WSS of LIMA at high, partial, and no competitive flow were 0.3-0.6, 0.6-3.0, and 0.9-3.0 Pa, respectively. Further, oscillatory WSS quantified as the oscillatory shear index (OSI) ranged from (maximum OSI = 0.5 equals zero net WSS) 0.15 to 0.35, <0.05, and <0.05, respectively. Thus, high competitive flow resulted in substantial oscillatory and low WSS. Moderate competitive flow resulted in WSS and OSI similar to the no competitive flow condition. CONCLUSION Graft flow is highly dependent on the degree of competitive flow. High competitive flow was found to produce unfavourable WSS consistent with endothelial dysfunction and subsequent graft narrowing and failure. Partial competitive flow, however, may be better tolerated as it was found to be similar to the ideal condition of no competitive flow.
Collapse
Affiliation(s)
- Håvard Nordgaard
- Department of Circulation and Medical Imaging, The Norwegian University of Science and Technology, N-7489 Trondheim, Norway.
| | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Taniguchi M, Akasaka T, Saito Y, Kaji S, Kawamoto T, Sukmawan R, Yoshitani H, Neishi Y, Ohe T, Tanemoto K, Yoshida K. Improvement of flow capacity of the left internal thoracic artery graft assessed by using a pressure wire. J Thorac Cardiovasc Surg 2007; 134:1012-6. [PMID: 17903522 DOI: 10.1016/j.jtcvs.2007.05.049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2007] [Revised: 04/11/2007] [Accepted: 05/11/2007] [Indexed: 11/19/2022]
Abstract
OBJECTIVE We sought to evaluate improvement of flow capacity in a left internal thoracic artery graft by means of pressure measurement. METHODS Eighteen patients who received a left internal thoracic artery graft to the left anterior descending coronary artery were studied. Angiography and pressure measurement at the proximal and distal portions of the left internal thoracic artery graft during maximal hyperemia with a pressure guide wire were performed at 1 month (early study) and 6 months (late study) after surgical intervention. RESULTS There are no significant differences between the early and late studies in resting mean aortic pressure, left ventricular end-diastolic pressure, left ventricular ejection fraction, and percentage diameter stenosis of the recipient left anterior descending coronary artery. There was no stenosis in the anastomosis site of the left internal thoracic artery graft and the distal left anterior descending coronary artery, as determined by means of angiography, in the early and late studies. The mean diameter of the distal left internal thoracic artery graft was significantly increased in the late study (1.6 +/- 0.2 vs. 1.8 +/- 0.2 mm, P = .011). There was a significant difference between the early and late studies in the pressure gradient through the graft (15 +/- 4 vs 13 +/- 3 mm Hg, P = .036). The ratio of distal to proximal pressure within the left internal thoracic artery graft in the late study was significantly increased from that in the early study (0.80 +/- 0.04 to 0.84 +/- 0.03, P = .0003). CONCLUSIONS The pressure ratio within the left internal thoracic artery graft became higher as the left internal thoracic artery graft adapted itself to the myocardial circulation. This finding might relate to decreasing the resistance of the left internal thoracic artery graft.
Collapse
Affiliation(s)
- Manabu Taniguchi
- Division of Cardiology, Kawasaki Medical School, Kurashiki, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, Bartunek J, Vanermen H, De Bruyne B. Long-term patency of internal mammary artery bypass grafts: relationship with preoperative severity of the native coronary artery stenosis. Circulation 2005; 110:II36-40. [PMID: 15364835 DOI: 10.1161/01.cir.0000141256.05740.69] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
BACKGROUND Internal mammary artery conduits (IMA) have an excellent long-term patency rate. Nevertheless, graft closure does occur and significantly limits future revascularization options. We sought to investigate the relationship between the long-term patency of IMA with clinical and angiographic parameters. Particularly, the preoperative degree of stenosis of the relevant bypassed coronary vessel was assessed to analyze the importance of chronic competitive flow on the arterial graft closure rate. METHODS AND RESULTS Consecutive patients in whom occlusion of at least 1 IMA had been documented at angiography (OCC group) were compared with a group of patients with patent IMA grafts (PAT group). The degree of stenosis in the native coronary artery on which the IMA was placed was analyzed by off-line quantitative coronary angiography. Multivariate stepwise logistic regression was used to identify independent clinical and angiographic predictors of occlusion. The OCC group comprised 96 patients (67+/-10 years) with 103 native bypassed arteries analyzed. The PAT group comprised 127 patients (69+/-8 years) with 170 native bypassed arteries analyzed. Both groups were similar except for gender (42% versus 32% female; P=0.04), height (166+/-8 versus 169+/-8 cm; P=0.006), minimum lumen diameter (0.76+/-0.7 versus 0.51+/-0.5; P=0.001), and diameter stenosis of the native artery (73+/-25% versus 84+/-16%; P<0.0001) in OCC versus PAT, respectively. In the multivariate analysis, only percent diameter stenosis was an independent and statistically significant predictor for graft patency. Among IMA placed on coronary arteries with a diameter of stenosis <50% (n=28), the occlusion rate was very high (79%). CONCLUSIONS The degree of stenosis in the native vessel is a major predictor of internal mammary artery bypass graft patency. The association between nonsignificant stenosis of the native artery and high occlusion rate of the arterial bypass conduit raises concerns about the use of IMA in the treatment of native vessels with only mild or moderate stenosis.
Collapse
|
11
|
Rodrigues AJ, Vicente WVA, Bassetto S, Filho AS. Anomalous origin of the left coronary artery from the pulmonary artery in an adult with systemic collateral circulation to the left coronary artery. Ann Thorac Surg 2004; 78:1082-4. [PMID: 15337058 DOI: 10.1016/s0003-4975(03)01421-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/23/2003] [Indexed: 10/26/2022]
Abstract
A case of anomalous origin of the left coronary artery from the pulmonary artery in an adult with collateral circulation between the left coronary artery and systemic extracardiac vessels is reported. After evaluating the surgical options, my colleagues and I conclude that ligation of the left coronary artery and a left internal thoracic artery graft to the left anterior descending coronary artery is the preferable option for treating such patients.
Collapse
Affiliation(s)
- Alfredo J Rodrigues
- Division of Cardiothoracic Surgery, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
| | | | | | | |
Collapse
|